Norihiro Sato
Sapporo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
The AMORE Score for Predicting the 5-Year Risk of Hemorrhagic Stroke in Asymptomatic Moyamoya Disease.
Journal: Cerebrovascular diseases (Basel, Switzerland)
Published: July 29, 2025
Trends in Invasive Interventions and Risk Factors for Early Critical Events in Multiple System Atrophy.
Journal: Cerebellum (London, England)
Published: May 18, 2025
The safety and effectiveness of transcatheter renal arterial embolization with tris-acryl gelatin microspheres in hemodialysis patients with autosomal dominant polycystic kidney disease.
Journal: Clinical and experimental nephrology
Published: January 20, 2025
Acellular, bioresorbable, ultra-purified alginate gel implantation for intervertebral disc herniation: Phase 1/2, open-label, non-randomized clinical trials.
Journal: Nature communications
Published: September 30, 2024
Assessment of factors associated with antipsychotic-induced weight gain: A nationwide cohort study.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: July 22, 2024
Disease progression, transient ischemic attack, and de novo parenchymal lesions in asymptomatic moyamoya disease: results of a 5-year interim analysis of the AMORE study.
Journal: Journal of neurosurgery
Published: March 26, 2024
The Movement Disorder Society Criteria: Its Clinical Usefulness in Multiple System Atrophy.
Journal: Internal medicine (Tokyo, Japan)
Published: March 18, 2024
Eribulin for patients with metastatic extramammary Paget disease: Study protocol for a single-arm phase II trial.
Journal: Experimental dermatology
Published: August 25, 2023
Risk factors for abnormal glucose metabolism during antipsychotic treatment: A prospective cohort study.
Journal: Journal of psychiatric research
Published: July 11, 2023
Last Updated: 09/26/2026